Heron Therapeutics (HRTX) Cash from Investing Activities (QoQ) (2010 - 2026)
Heron Therapeutics (HRTX) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -247.71% |
| Mar 31, 2026 | 82.79% |
| Dec 31, 2025 | -146.01% |
| Sep 30, 2025 | 61.69% |
| Jun 30, 2025 | 222.66% |
| Mar 31, 2025 | -80.09% |
| Dec 31, 2024 | 187.61% |
| Sep 30, 2024 | 93.85% |
| Jun 30, 2024 | 60.25% |
| Mar 31, 2024 | 114.46% |
| Dec 31, 2023 | 61.95% |
| Sep 30, 2023 | -275.68% |
| Jun 30, 2023 | -64.11% |
| Mar 31, 2023 | 1,722.56% |
| Dec 31, 2022 | 105.61% |
| Sep 30, 2022 | -282.46% |
| Jun 30, 2022 | 80.49% |
| Mar 31, 2022 | 145.12% |
| Dec 31, 2021 | -212.13% |
| Sep 30, 2021 | -45.50% |